Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

S(-)-satropane

Known as: lesatropane 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Lesatropane, a synthesized chiral tropane (3S, 6S-isomer of satropane), is a novel muscarinic agonist, and is being under… Expand
Is this relevant?
2013
2013
Lesatropane, a synthesized chiral tropane (S, S-isomer of satropane), is a novel muscarinic agonist, and is being under… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Lesatropane is a novel muscarinic receptor agonist and is currently being under preclinical development in China as a single… Expand
Is this relevant?
2010
2010
The title compound, C(15)H(22)NO(4)S(+)·Cl(-), is a hydrolysis product of lesatropane [(1R,3S,5R,6S)-6-acet-oxy-3-tosyl… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2009
2009
The title compound, C17H24NO5S+·C18H13O8 −, is the key intermediate during the preparation of lesatropane [systematic name (1R,3S… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2008
2008
S(-)-Satropane is currently being developed to in situ forming ophthalmic gel, a new ophthalmic delivery system, for the… Expand
Is this relevant?
2008
2008
AbstractAim:To study the stereoselectivity of satropane (3-paramethylbenzene sulfonyloxy-6-acetoxy tropane), a novel tropane… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?